Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Levin Explains to New Senior Investment Group Inc (SNR)’s Board Why the Stock Is Slumping

According to a recent filing with the Securities and Exchange Commission Levin Capital Strategies, which is managed by John A. Levin, has further trimmed its stake in New Senior Investment Group Inc (NYSE:SNR) to 4.48 million shares from 4.51 million shares. The stake, which is held together with affiliated entities, amasses about 5.18% of the company’s outstanding stock. Out of these, 680,618 shares grant Levin Capital sole voting power while about 3.27 million shares represent shared voting power. Additionally, Levin Capital has also entered into swap contracts involving 137,263 shares of New Senior Investment Group with an affiliate of JP Morgan. Accompanying this new development is the letter that Levin recently has sent to New Senior Investment Group Inc (NYSE:SNR)’s management in connection with the company’s slumping stock price which he believes is rooted in the external management by Fortress.

John Levin Levin Capital

Levin served as President of the BKF Capital Group before he established the New York City-based Levin Capital Strategies in 2005. Most of the fund’s picks are large-cap companies that satisfy the fund’s bottom-up approach. Currently, the value of Levin Capital’s public equity portfolio stands at $6.76 billion, with 17% of the holdings belonging to the finance sector, one of which is New Senior Investment Group Inc (NYSE:SNR).

Following activist funds like Levin Capital is important because it is a very specific and focused strategy in which the investor doesn’t have to wait for catalysts to realize gains in the holding. A fund like Levin Capital can simply create its own catalysts by pushing for them through negotiations with the company’s management and directors. In recent years, the average returns of activist hedge funds have been much higher than the returns of an average hedge fund. Furthermore, we believe do-it-yourself investors have an advantage over activist hedge fund investors because they don’t have to pay 2% of their assets and 20% of their gains every year to compensate hedge fund managers. We have found through extensive research that the top small-cap picks of hedge funds are also capable of generating high returns and built a system around this premise. In the 37 months since our small-cap strategy was launched it has returned over 118% and beaten the S&P 500 ETF (SPY) by more than 60 percentage points (read more details here).

John A. Levin
John A. Levin
Levin Capital Strategies

In his letter to New Senior Investment Group Inc (NYSE:SNR), Levin highlighted the more than 50% drop in the company’s stock price since its spinoff from Newcastle Investment Corp. (NYSE:NCT) in October 2014. This slump has come despite an impressive performance by CEO Susan Givens, who managed to increase occupancy rates at the company’s properties and also considerably grow its Funds from Operations (FFO).

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.